is it worth you sending, maybe a revised verison to our new CEO who said she would welcome shareholder insight?
what you have of course mentioned make sense enough,
and of course why does it seem buried? are others adn T&C in agreement mean that they can bury it for now so it doesn't compete with commerical lifecycle of current prodcut az have?
these things are done all the time.
D and O Agreement with AstraZeneca, page-3
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $42.78M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43696 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 130967 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |